COUGH is the #5 most commonly reported adverse reaction for CEFPODOXIME PROXETIL, manufactured by Amici Pharmaceuticals, LLC.. There are 43 FDA adverse event reports linking CEFPODOXIME PROXETIL to COUGH. This represents approximately 2.3% of all 1,861 adverse event reports for this drug.
Patients taking CEFPODOXIME PROXETIL who experience cough should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
Reporting Frequency
COUGH43 of 1,861 reports
COUGH is a less commonly reported adverse event for CEFPODOXIME PROXETIL, but still significant enough to appear in the safety profile.
Other Side Effects of CEFPODOXIME PROXETIL
In addition to cough, the following adverse reactions have been reported for CEFPODOXIME PROXETIL:
COUGH has been reported as an adverse event in 43 FDA reports for CEFPODOXIME PROXETIL. This does not prove causation, but indicates an association observed in post-market surveillance data.
How common is COUGH with CEFPODOXIME PROXETIL?
COUGH accounts for approximately 2.3% of all adverse event reports for CEFPODOXIME PROXETIL, making it a notable side effect.
What should I do if I experience COUGH while taking CEFPODOXIME PROXETIL?
If you experience cough while taking CEFPODOXIME PROXETIL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.